MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • MDS Virtual Congress 2021

    Progressive Gait Disturbance presumed to be caused by idiopathic peripheral neuropathy: A case of Normal Pressure hydrocephalus.

    K. Dalton, N. Hack (Bethesda, USA)

    Objective: Discuss the importance of gait phenomenology in identifying Normal Pressure Hydrocephalus. Background: Normal pressure hydrocephalus (iNPH) can present as a ‘magnetic gait’ but this…
  • MDS Virtual Congress 2021

    Sex-Specific APOE ε4 Association with Cognition in Lewy Body Dementia

    E. Bayram, S. Scholz, I. Litvan (La Jolla, USA)

    Objective: To evaluate whether association between apolipoprotein E ε4 (APOE ε4) and cognition differ for men and women with pathologically-confirmed Lewy body dementia (LBD). Background:…
  • MDS Virtual Congress 2021

    Motor and non-motor effects of mevidalen in Lewy Body Dementia as measured by the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

    K. Biglan, L. Munsie, K. Svensson, P. Ardayfio, M. Pugh, J. Sims, M. Brys (Indianapolis, USA)

    Objective: To assess the motor and non-motor effects of mevidalen in patients with Lewy Body Dementia (LBD) as measured by the MDS-UPDRS. Background: Mevidalen is…
  • MDS Virtual Congress 2021

    Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

    J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

    Objective: To identify the associations between Alzheimer Disease (AD) co-pathology and neuropsychiatric symptoms in Lewy body dementia (LBD). Background: Dementia with Lewy Bodies (DLB) and…
  • MDS Virtual Congress 2021

    Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)

    JM. Perez Imbernon, S. Lopez Calvo, F. Castillo Alvarez, MT. Marti Sanchez, MM. Zambrano Vera, N. Reurich Gomez, ME. Marzo Sola (Logroño, Spain)

    Objective: To present a Parkinson´s Disease (PD) patient who presented a rapidly progressive dementia after MR-FUS therapy. Background: MR-FUS thalamotomy is used for unilateral essential…
  • MDS Virtual Congress 2021

    Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias

    I. Walker, S. Shaw, S. Vaishnavi, D. Wolk, N. Dahodwala, J. Morley, J. Duda, A. Chen-Plotkin, A. Siderowf, L. Shaw, E. Lee, J. Trojanowski, M. Grossman, D. Weintraub, D. Irwin (Philadelphia, USA)

    Objective: To investigate the clinical influence of Alzheimer’s disease (AD) co-pathology on motor features in Lewy Body Dementia (LBD). Background: There is considerable heterogeneity of…
  • MDS Virtual Congress 2021

    ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE

    C. Borrue-Fernandez, E. Ferriz (San Sebastian Reyes, Spain)

    Objective: The main objective of the study was to analyze the association between insulin resistance (IR ) at  diagnosis and the development of dementia in…
  • MDS Virtual Congress 2021

    Cognitive impairment in patients with Alzheimer’s disease and Parkinson’s disease

    O. Chyniak (Sumy, Ukraine)

    Objective: To compare the results of a neuropsychological study in patients with Alzheimer's disease and Parkinson's disease. Background: Recently, Parkinson's disease (PD) is increasingly considered…
  • MDS Virtual Congress 2021

    Cognitive-driven ADL impairment as a predictor for PDD

    I. Liepelt-Scarfone, M. Bode, K. Brockmann, T. Gasser, K. Michaelis, S. Nussbaum, HC. Nuerk, C. Schulte, W. Maetzler, M. Zimmermann, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To evaluate whether Parkinson’s disease (PD) patients with mild activity of daily living (ADL) impairment are at higher risk for developing dementia (PDD). Background:…
  • MDS Virtual Congress 2021

    Sex-Specific White Matter Correlates of Neuropsychological Measures in Parkinson’s disease with Mild Cognitive Impairment

    V. Mishra, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari, J. Caldwell (Las Vegas, USA)

    Objective: To identify sex-specific white-matter (WM) correlates of neuropsychological measures in Parkinson’s disease (PD) with mild cognitive impairment (MCI). Background: Neuropsychological measures of executive function…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley